Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala 147002, Punjab, India.
Fundam Clin Pharmacol. 2012 Jun;26(3):347-55. doi: 10.1111/j.1472-8206.2011.00936.x. Epub 2011 Mar 11.
The present study was designed to investigate the possible role of endogenous opioids and K(ATP) channels in glycerol-induced acute renal failure (ARF) in rats. The rats were subjected to rhabdomyolytic ARF by single intramuscular injection of hypertonic glycerol (50% v/v; 8 mL/kg), and the animals were sacrificed after 24 h of glycerol injection. The plasma creatinine, blood urea nitrogen, creatinine clearance, and histopathological studies were performed to assess the degree of renal injury. Naltrexone (2.5, 5.0 and 10.0 mg/kg s.c.), glibenclamide (5.0 and 10.0 mg/kg i.p.), and minoxidil (25 and 50 mg/kg) were employed to explore the role of endogenous opioids and K(ATP) channels in rhabdomyolysis-induced ARF. Pretreatment with naltrexone and glibenclamide attenuated hypertonic glycerol-induced renal dysfunction in a dose-dependent manner, suggesting the role of endogenous opioids and K(ATP) channels in the pathogenesis of myoglobuniric renal failure. However, the simultaneous pretreatment with naltrexone (10 mg/kg s.c.) and glibenclamide (10 mg/kg i.p.) did not enhance the reno-protective effects of individual drugs, suggesting that release of endogenous opioids and opening of K(ATP) channels constitute a single pathway in acute renal injury triggered by hypertonic glycerol-induced rhabdomyolysis. Furthermore, administration of minoxidil abolished the attenuating effects of naltrexone in glycerol-induced renal failure, suggesting that opening of K(ATP) channels is downstream to opioid receptor activation. It is concluded that hypertonic glycerol-induced rhabdomyolysis may involve release of endogenous opioids that in turn modulate K(ATP) channels to contribute in the pathogenesis of ARF.
本研究旨在探讨内源性阿片肽和 K(ATP) 通道在甘油诱导的大鼠急性肾衰竭(ARF)中的可能作用。通过单次肌肉内注射高渗甘油(50%,v/v;8 mL/kg)诱导肌溶解型 ARF,甘油注射 24 小时后处死动物。进行血浆肌酐、血尿素氮、肌酐清除率和组织病理学研究,以评估肾损伤程度。纳曲酮(2.5、5.0 和 10.0 mg/kg,皮下注射)、格列本脲(5.0 和 10.0 mg/kg,腹腔注射)和米诺地尔(25 和 50 mg/kg)用于探讨内源性阿片肽和 K(ATP) 通道在肌红蛋白尿性肾衰竭中的作用。纳曲酮和格列本脲预处理以剂量依赖性方式减轻高渗甘油诱导的肾功能障碍,表明内源性阿片肽和 K(ATP) 通道在肌红蛋白尿性肾衰竭发病机制中的作用。然而,同时给予纳曲酮(10 mg/kg,皮下注射)和格列本脲(10 mg/kg,腹腔注射)不能增强两种药物的肾保护作用,表明内源性阿片肽的释放和 K(ATP) 通道的开放构成了高渗甘油诱导的肌溶解引起的急性肾损伤的单一途径。此外,米诺地尔的给药消除了纳曲酮在甘油诱导的肾衰竭中的减弱作用,表明 K(ATP) 通道的开放是阿片受体激活的下游事件。总之,高渗甘油诱导的肌溶解可能涉及内源性阿片肽的释放,这些阿片肽反过来调节 K(ATP) 通道,有助于 ARF 的发病机制。